Kalaris Therapeutics (KLRS) Stock Chart & Stock Price History $2.40 -0.17 (-6.61%) As of 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock Kalaris Therapeutics Stock Price Performance The Kalaris Therapeutics (KLRS) stock chart highlights key performance trends across multiple timeframes. As of the latest close, Kalaris Therapeutics traded at $2.57 with a market cap of $48.06 million and volume of 36,260 shares. Receive KLRS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kalaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-9.09% KLRS Stock Chart for Friday, June, 20, 2025 KLRS Chart by TradingView Kalaris Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/20/2025$2.57$2.40-6.61%$2.75$2.32150,144 shs$44.88 million06/19/2025$2.57$2.57$2.67$2.5536,260 shs$48.06 million06/18/2025$2.56$2.57+0.39%$2.67$2.5536,260 shs$48.06 million06/17/2025$2.67$2.56-4.12%$2.85$2.5169,539 shs$47.88 million06/16/2025$2.64$2.67+1.14%$2.78$2.5618,855 shs$49.93 million06/13/2025$2.76$2.64-4.35%$2.76$2.4553,508 shs$49.37 million06/12/2025$2.90$2.76-4.83%$3.08$2.7622,290 shs$51.62 million06/11/2025$3.08$2.90-5.84%$3.22$2.8040,726 shs$54.24 million06/10/2025$3.06$3.08+0.65%$3.32$3.0624,873 shs$57.60 million06/09/2025$3.30$3.06-7.27%$3.53$3.0690,838 shs$57.23 million Get the Latest News and Ratings for KLRS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kalaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/06/2025$3.11$3.30+6.11%$3.35$3.0230,130 shs$61.72 million06/05/2025$3.09$3.11+0.65%$3.25$3.0018,307 shs$58.16 million06/04/2025$3.08$3.09+0.32%$3.15$2.9571,268 shs$57.79 million06/03/2025$3.00$3.08+2.67%$3.08$2.9222,002 shs$57.60 million06/02/2025$2.92$3.00+2.74%$3.03$2.9011,867 shs$56.11 million05/30/2025$2.96$2.92-1.35%$3.10$2.8816,200 shs$54.61 million05/29/2025$2.90$2.96+2.07%$3.04$2.8018,214 shs$55.36 million05/28/2025$2.91$2.90-0.34%$3.04$2.8116,357 shs$54.24 million05/27/2025$2.79$2.91+4.30%$2.94$2.7939,617 shs$54.42 million05/26/2025$2.79$2.79$2.87$2.65119,062 shs$52.18 million Related Companies AVTE Stock Chart ACIU Stock Chart DRUG Stock Chart PRME Stock Chart SOPH Stock Chart CYBN Stock Chart OGI Stock Chart NLTX Stock Chart LRMR Stock Chart VYGR Stock Chart Receive KLRS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kalaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KLRS) was last updated on 6/20/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredMost Bitcoin holders have no idea this existsHere’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...Brownstone Research | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kalaris Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kalaris Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
